How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?

Keeping Current ›

19:55 | Dec 5th, 2025

Where do oral selective estrogen receptor degraders (SERDs) fit in the overall landscape of first- and second-line advanced/metastatic breast cancer? Credit available for this activity expires: 12/04/...Show More